Levorphanol: the forgotten opioid

@article{Prommer2006LevorphanolTF,
  title={Levorphanol: the forgotten opioid},
  author={E. Prommer},
  journal={Supportive Care in Cancer},
  year={2006},
  volume={15},
  pages={259-264}
}
  • E. Prommer
  • Published 2006
  • Medicine
  • Supportive Care in Cancer
    • BackgroundLevorphanol (levo-3-hydroxy-N-methylmorphinan) is a strong opioid that is the only available opioid agonist of the morphinan series. Levorphanol was originally synthesized as a pharmacological alternative to morphine more than 40 years ago. It is considered a step-3 opioid by the World Health Organization (WHO) and has a greater potency than morphine. Analgesia produced by levorphanol is mediated via its interactions with μ, δ, and κ opioid receptors. Levorphanol is also an N-methyl-d… CONTINUE READING
    View on Springer
    paindr.com
    Top 3 of 31 Citations
    Levorphanol use: past, present and future
    J. Gudin, J. Fudin, S. NalamachuPostgraduate medicine2016
    17
    Is levorphanol a better option than methadone?
    T. Pham, J. Fudin, R. RaffaPain medicine2015
    16
    Levorphanol: Revisiting an Underutilized Analgesic
    E. PrommerPalliative care2014
    9
    31 Citations
    Citation Type

    Citation Type

    Levorphanol use: past, present and future
    • 17
    • PDF
    Is levorphanol a better option than methadone?
    • 16
    • PDF
    Levorphanol: Revisiting an Underutilized Analgesic
    • 9
    • PDF
    Pharmacology of opioids in the treatment of chronic pain syndromes.
    • 87
    Metabolism and Disposition of Prescription Opioids: A Review.
    • 43
    Pharmacogenetics of chronic pain management.
    • 75
    • PDF
    Pharmacological Characterization of Levorphanol, a G-Protein Biased Opioid Analgesic
    • 4
    Opioid switching and rotation in primary care: implementation and clinical utility
    • 79
    Opioids and Cardiac Arrhythmia: A Literature Review
    • 30
    Medication pain management in the elderly: unique and underutilized analgesic treatment options.
    • 41
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 27 REFERENCES
    Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception.
    • 300
    Oral opioid therapy for chronic peripheral and central neuropathic pain.
    • 498
    Sublingual absorption of selected opioid analgesics
    • 251
    Pharmacokinetic-pharmacodynamic modeling of opioids.
    • 165
    Opioid analgesics: comparative features and prescribing guidelines.
    • 78
    Unidirectional analgesic cross-tolerance between morphine and levorphanol in the rat
    • 46
    Kappa3 receptors and levorphanol-induced analgesia
    • 21
    Levorphanol: pharmacokinetics and steady-state plasma concentrations in patients with pain.
    • 21
    • Highly Influential
    Differential agonist regulation of the human kappa-opioid receptor.
    • 24
    Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.
    • 69